Nasus Pharma Ltd. Insider Trading
NSRX
Insiders bought 62K on the open market and sold nothing.
Get an email when NSRX's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Jun 17 | Dan Benjamin Teleman Chief Executive Officer | Bought | 6,550 | $3.10 | 20K | 4.2% | Form 4 |
| Apr 22 | Dan Benjamin Teleman Chief Executive Officer | Bought | 2,900 | $3.76 | 11K | 1.9% | Form 4 |
| Mar 31 | Dan Benjamin Teleman Chief Executive Officer | Bought | 15,000 | $2.04 | 31K | 240% | Form 4 |
- Jun 17Dan Benjamin TelemanChief Executive Officer · bought 6,550 at $3.1020K4.2% of stake
- Apr 22Dan Benjamin TelemanChief Executive Officer · bought 2,900 at $3.7611K1.9% of stake
- Mar 31Dan Benjamin TelemanChief Executive Officer · bought 15,000 at $2.0431K240% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Drug Manufacturers - General · Pick stocks to compare with NSRX
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing NSRX
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.